The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]-1-methyl-3-(5-methylisoxazol-3-yl)-1H-pyrazole-4-carboxamide
ID: ALA4584251
PubChem CID: 155566085
Max Phase: Preclinical
Molecular Formula: C19H23N5O2
Molecular Weight: 353.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=O)c2cn(C)nc2-c2cc(C)on2)cc1
Standard InChI: InChI=1S/C19H23N5O2/c1-5-24(6-2)15-9-7-14(8-10-15)20-19(25)16-12-23(4)21-18(16)17-11-13(3)26-22-17/h7-12H,5-6H2,1-4H3,(H,20,25)
Standard InChI Key: MFWITLJFMFWRHZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
3.7105 -18.9013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7075 -19.7226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4874 -19.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9719 -19.3186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4922 -18.6540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7048 -17.8607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1882 -17.2227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6353 -16.5342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4282 -16.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4712 -17.5665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0090 -16.1659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7933 -19.3204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2045 -20.0289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0258 -20.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4305 -20.7424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2511 -20.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6662 -20.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2505 -19.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4313 -19.3235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4875 -20.0337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8955 -20.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7168 -20.7465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8966 -19.3263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7179 -19.3270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2075 -18.6094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9962 -20.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
6 5 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
9 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 1 0
12 25 2 0
2 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 353.43 | Molecular Weight (Monoisotopic): 353.1852 | AlogP: 3.48 | #Rotatable Bonds: 6 |
Polar Surface Area: 76.19 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.42 | CX LogP: 3.30 | CX LogD: 3.29 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.73 | Np Likeness Score: -2.31 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |